Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Zika virus effective in eliminating neuroblastoma tumors in mice, study finds

Injecting neuroblastoma tumors with Zika virus shrank or eliminated those tumors in studies with mice, suggesting that the virus could someday serve as an effective cancer therapy, according to a study led by Nemours Children's Health researchers and published today in Cancer Research Communications, a journal of the American Association for Cancer Research.

9 Jan 2024

New study sheds light on the biological properties of new COVID variant Pirola

Despite the end of the pandemic, COVID-19 continues to pose a serious health threat. Most individuals have established robust immune protection and do not develop severe disease but the infection can still lead to marked and sometimes long-lasting disease symptoms.

9 Jan 2024

Researchers unravel the workings of Group B Strep infections in pregnant women

Researchers from Binghamton University, State University of New York are unraveling the workings of Group B Strep (GBS) infections in pregnant women, which could someday lead to a vaccine.

9 Jan 2024

Measuring airborne grass allergen levels could be key to controlling hay fever symptoms

Measuring airborne grass allergen levels instead of pollen counts will be more beneficial for hay fever sufferers as new research shows grass allergen levels are more consistently associated with hay fever symptoms than grass pollen counts.

8 Jan 2024

Study finds Epstein-Barr virus T-cells prevalent in early multiple sclerosis

A study led by UTHealth Houston reveals that T-cells specific for Epstein-Barr virus-infected cells are highly present in the cerebrospinal fluid of people with early-stage multiple sclerosis, suggesting a link between EBV and the disease.

8 Jan 2024

There’s a new covid-19 variant and cases are ticking up. What do you need to know?

It's winter, that cozy season that brings crackling fireplaces, indoor gatherings — and a wave of respiratory illness.

8 Jan 2024

Does SARS-CoV-2's ability to infect humans stem from its evolutionary past?

Study challenges the hypothesis of genetic recombination in SARS-CoV-2's evolution, suggesting its ancestral virus already possessed human-infecting traits, based on analyses of over 100 viral genomes.

7 Jan 2024

University of Louisville scientists aim to disarm Yersinia pestis, the bubonic plague bacteria

When the body encounters bacteria, viruses or harmful substances, its innate immune cells, neutrophils, assemble at the site to combat the invader.

5 Jan 2024

Fruit fly research solves human disease and fuels new cancer immunotherapy approach

Scientists have solved a cellular murder mystery nearly 25 years after the case went cold. Following a trail of evidence from fruit flies to mice to humans revealed that cannibalistic cells likely cause a rare human immunodeficiency.

5 Jan 2024

Stapled lipopeptides show promise as broad-spectrum antiviral agents

Compounds that obstruct the "landing gear" of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19, a study published today and led by Dana-Farber Cancer Institute scientists shows.

5 Jan 2024

Psychedelic drug offers lifesaving relief for veterans plagued by traumatic brain injury

For military veterans, many of the deepest wounds of war are invisible: Traumatic brain injuries resulting from head trauma or blast explosions are a leading cause of post-traumatic stress disorder, anxiety, depression and suicide among veterans.

5 Jan 2024

Scripps Research commemorates 100 years of innovation in science and medicine

Scripps Research, a nonprofit biomedical institute ranked one of the most influential in the world for its impact on innovation, will celebrate its 100-year history throughout 2024.

5 Jan 2024

UKHSA urges eligible groups to get vaccinated against flu and COVID-19

The UK Health Security Agency (UKHSA) is reminding all those eligible that it's not too late to book their flu and COVID-19 vaccinations.

5 Jan 2024

ATCC announces new award from BARDA to provide centralized storage and bioprocessing services for Project NextGen

ATCC, the world’s premier biological materials management and standards organization, today announced a five-year, $87 million award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to support the development of next-generation medical countermeasures (MCMs) to protect Americans from public health security threats such as coronaviruses.

From ATCC 5 Jan 2024

AI model predicts future spread of SARS-CoV-2 variants using genomic data

Researchers developed an AI-based model to predict the spread of new SARS-CoV-2 variants, analyzing nine million genomic sequences across 30 countries and incorporating factors like vaccination rates and non-pharmaceutical interventions.

4 Jan 2024

Heart-healthy diet boosts patient satisfaction and safety before cardiac catheterization

The days of prolonged fasting prior to cardiac catheterization may be numbered, as the body of evidence grows to allow patients to eat before the procedure.

3 Jan 2024

Do hospitalized COVID-19 patients have long-term cognitive, psychiatric, or neurological complications?

Researchers assessed whether psychiatric, neurological, and cognitive complications among patients hospitalized for COVID-19 differ from those with other medical conditions of similar severity.

3 Jan 2024

RSV vaccines would dramatically reduce disease burden if widely adopted like flu shots

Respiratory syncytial virus (RSV) vaccines recently approved for people 60 and older would dramatically reduce the disease's significant burden of illness and death in the United States if they were widely adopted like annual influenza vaccines, a new study has found.

2 Jan 2024

AI tool tracks mutations to predict next COVID variant wave

An AI model can predict which SARS-CoV-2 variants are likely to cause new waves of infection. Current models used to predict the dynamics of viral transmission do not predict variant-specific spread.

2 Jan 2024

Researchers receive two grants to study tuberculosis drug development

Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis (TB) drug development.

26 Dec 2023

Previous
1
...
51
52
53
54
55
56
57
...
1183
Next

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Zika virus effective in eliminating neuroblastoma tumors in mice, study finds

New study sheds light on the biological properties of new COVID variant Pirola

Researchers unravel the workings of Group B Strep infections in pregnant women

Measuring airborne grass allergen levels could be key to controlling hay fever symptoms

Study finds Epstein-Barr virus T-cells prevalent in early multiple sclerosis

There’s a new covid-19 variant and cases are ticking up. What do you need to know?

Does SARS-CoV-2's ability to infect humans stem from its evolutionary past?

University of Louisville scientists aim to disarm Yersinia pestis, the bubonic plague bacteria

Fruit fly research solves human disease and fuels new cancer immunotherapy approach

Stapled lipopeptides show promise as broad-spectrum antiviral agents

Psychedelic drug offers lifesaving relief for veterans plagued by traumatic brain injury

Scripps Research commemorates 100 years of innovation in science and medicine

UKHSA urges eligible groups to get vaccinated against flu and COVID-19

ATCC announces new award from BARDA to provide centralized storage and bioprocessing services for Project NextGen

AI model predicts future spread of SARS-CoV-2 variants using genomic data

Heart-healthy diet boosts patient satisfaction and safety before cardiac catheterization

Do hospitalized COVID-19 patients have long-term cognitive, psychiatric, or neurological complications?

RSV vaccines would dramatically reduce disease burden if widely adopted like flu shots

AI tool tracks mutations to predict next COVID variant wave

Researchers receive two grants to study tuberculosis drug development

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in